Sentonix

Sentonix is an emerging biopharmaceutical company. The company focuses on areas such as cancer immunotherapy and currently concentrates on Parkinson's disease, Alzheimer's disease, and other neurodegenerative disease fields, committing to the early discovery and clinical translation of next-generation innovative drugs.